Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jasmate Klinika Mouthwash is a herbal-based oral formulation developed for the management of dentin hypersensitivity. It contains a combination of 5% potassium nitrate and 2% curcumin. Potassium nitrate acts as a desensitizing agent by increasing extracellular potassium ion concentration, which depolarizes the nerve endings in the dental pulp and prevents the transmission of pain signals. Curcumin, a bioactive compound from turmeric, provides anti-inflammatory and antioxidant properties to support oral health and reduce gingival inflammation. The formulation is being evaluated in a randomized, single-blind Phase 3 clinical trial (NCT06627790) sponsored by Dr. D. Y. Patil Dental College & Hospital to compare its efficacy against standard potassium oxalate-based mouthwashes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jasmate Klinika Mouthwash.